[Edaily Starin Choi Hee-jae Reporter] Three executives at T&N Entertainment (T&N Ent.) have been implicated in allegations of breach of trust in the course of their duties. (Graphic: Image generated by Gemini AI) According to the Financial Supervisory Service’s electronic disclosure system on the 28th, T&N Entertainment confirmed on the 24th that executives A, B, and C are suspected of breach of trust in the course of their duties. The company stated that it plans to take necessary measures in accordance with legal procedures, such as filing claims for damages, regarding all matters that arise in the future. It also explained that it intends to actively cooperate with investigations by relevant authorities. However, the amount involved in the breach of trust has not yet been determined. Consequently, if it is later confirmed to exceed 3% of the company’s equity or 1 billion won, the company may be subject to a substantive review of its listing eligibility. The company’s equity stands at 66.97096 billion won as of the end of 2025, based on its individual financial statements. T&N Entertainment plans to disclose the details once the amount of the breach of trust is finalized through court rulings or other proceedings. T&N Entertainment’s roster includes the comedian couple Kang Jae-jun and Lee Eun-hyung; Kim Sook; Kim Ji-sun; Nam Chang-hee; Jang Dong-min; Hong Hyun-hee; broadcasters Kang Ji-young, Do Kyung-wan, Boom, Yang Se-hyung, Yoo Se-yoon, Lee Young-ja, Heo Kyung-hwan, and Hong Jin-kyung; actors Ra Mi-ran and Jung Ji-so; the singer couple Moon Hee-jun and So-yul; and chef Yoon Nam-no. Former flagship artists such as Jang Yoon-jung and Lee Chan-won have moved to new agencies.
A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
(Graphic: Generative AI)
During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…